Key Ratio
USD
325.89
- (-0.1%)
NYSE:PWR, QUANTA SERVICES, INC.
Industry: Engineering & Construction
End of Day: 9 May 2025 GMT-4
Income Statement Ratios
Fiscal
Gross Profit Margin
14.10%
Net Profit Margin (Adj.)
3.60%
Return on Equity (Adj.)
11.80%
Fiscal (USD)
Period End Date
Financials
Revenue
Gross Profit
EBITDA
Operating Profit
Net Income (To Shareholders)
Net Income (Adj.)
Ratios
Gross Profit Margin
EBITDA Margin
Operating Margin
Net Profit Margin (Adj.)
Return on Equity (Adj.)
Return on Equity (Adj.) 3Y
Return on Equity (Adj.) 5Y
Return on Assets (Adj.)
Return On Invested Capital (Adj.)
ROIIC 3Y
ROIIC 10Y
Degree Of Op. Leverage (EBIT)
Degree Of Op. Leverage (CFO)
Rule Of 40 (EBITDA)
Rule Of 40 (FCF)
Per Share
Revenue / Share
Operating Profit / Share
Diluted EPS
Diluted EPS (Adj.)
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
20,882
20,882
2,937
2,937
1,445
1,445
1,092
1,092
744
744
606
606
14.1%
14.1%
6.9%
6.9%
5.5%
5.5%
3.6%
3.6%
12.4%
11.8%
10.5%
9.8%
10.2%
9.7%
4.5%
4.5%
8.9%
8.9%
9.8%
9.8%
8.7%
5.3%
1.4x
1.4x
-
0.1x
29.2
29.2
-
25.8
143
143
7.5
7.5
5.0
5.0
5.0
5.0
In Millions except per share items.
Balance Sheet Ratios
Fiscal
Current Ratio
1.50x
Cash Ratio
0.200x
Total Debt to Equity Ratio
0.700x
Fiscal (USD)
Period End Date
Financials
Short Term Cash Investments
Total Assets
Total Debt
Total Liabilities
Total Equity
Ratios
Current Ratio
Cash Ratio
Total Debt to Equity Ratio
Net Debt (Cash) to Equity
Net Debt (Cash) to NTA
Cash Conversion Cycle
Avg Days Sales Out.
Avg Days Inventory Out.
Avg Days Payables Out.
Per Share
Total Assets / Share
Book Value/Share
Tangible Book Value / Share
Total Debt / Share
Cash / Share
Net Debt (Cash) / Share
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
1,290
1,290
16,237
16,237
4,463
4,463
9,953
9,953
6,272
6,272
1.5x
1.5x
0.2x
0.2x
0.7x
0.7x
0.5x
0.5x
3.7x
3.7x
-
40.5
70.0
70.0
2.0
2.0
-
36.9
111
111
43.2
43.2
5.9
5.9
30.7
30.7
8.9
8.9
21.8
21.8
In Millions except per share items.
Cash Flow Ratios
Fiscal (USD, MM)
Cash From Operations
1,155
CAPEX
-
Free Cash Flow (FCF)
731
Fiscal (USD)
Period End Date
Financials
CFO bef. W.C. Changes
Cash From Operations
CAPEX
Cash Flow From Investing
Cash Flow From Financing
Free Cash Flow (FCF)
Ratios
FCF Margin
Quality Of Earnings
Dividend Payout Ratio
Per Share
Cash From Operations / Share
Free Cash Flow / Share
Dividend / Share
Special Dividend / Share
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
-
-
-
1,155
-
-
-
-
-
-
-
731
-
3.5%
-
1.6x
-
-
-
8.0
-
5.0
0.3
0.3
-
-
In Millions except per share items.
Valuation Ratios
Fiscal
Price / Sales
1.50x
Price / Earnings (Adj.)
53.00x
Price / Tangible Book
36.30x
Fiscal (USD)
Period End Date
Dividend Yield
Special Dividend Yield
Price / Sales
Price / Earnings (Adj.)
Price / Book
Price / Tangible Book
Price / CFO
Price / FCF
EV / EBIT
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
0.2%
0.2%
-
-
1.5x
1.5x
53.0x
53.0x
5.0x
5.0x
36.3x
36.3x
-
27.1x
-
42.9x
29.4x
29.4x
Other Ratios
Fiscal (USD)
Period End Date
Revenue Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Operating Profit Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Net Income (Adj.) Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Diluted (Adj.) EPS Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Cash From Operations Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
Free Cash Flow Growth
Year-On-Year
3 Year CAGR
5 Year CAGR
10 Year CAGR
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
22.3%
22.3%
23.1%
23.1%
-
13.3%
-
12.3%
30.3%
30.3%
21.5%
21.5%
-
13.6%
-
7.6%
37.8%
37.8%
19.3%
19.3%
16.2%
16.2%
4.3%
4.3%
47.5%
47.5%
17.3%
17.3%
-
19.6%
-
10.4%
-
2.2%
-
1.2%
-
26.4%
-
10.0%
-
4.2%
-
-5.1%
-
70.5%
-
14.9%
Fiscal (USD)
Period End Date
Market Capitalization
Total Enterprise Value
Shares Outstanding
FY23
31 Dec 2023
LTM23 Q4
PR
31 Dec 2023
28.1925b
28.1925b
32.1349b
32.1349b
145.2849m
145.2849m
- Figures shown are in its reported currency unless stated otherwise.
- Net Income and its respective ratios are normalised for one-off items unless stated otherwise.
- PR = Press Release
- FYC = Financial Year Change
Make Smart Investment Choices